How many 8-K filings has Transmedics Group, Inc. filed?

Transmedics Group, Inc. (TMDX) has 19 8-K (Current Event Report) filings on record, spanning Jan 2024 to Oct 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Transmedics Group, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Transmedics Group, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Transmedics Group, Inc. (TMDX) — 8-K Filings

All 8-K filings from Transmedics Group, Inc.. Browse 19 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (19)

TransMedics Completes Asset Acquisition/Disposition — Oct 6, 2025 Risk: medium
TransMedics Group, Inc. announced the completion of an acquisition or disposition of assets on October 3, 2025. The filing does not specify the nature of the as
TransMedics Group Files 8-K on Shareholder Vote Matters — May 23, 2025 Risk: low
TransMedics Group, Inc. filed an 8-K on May 23, 2025, reporting on matters submitted to a vote of its security holders as of May 22, 2025. The filing details th
TransMedics Group Files 8-K on Financials — Feb 27, 2025 Risk: low
TransMedics Group, Inc. filed an 8-K on February 27, 2025, reporting on its results of operations and financial condition. The filing includes financial stateme
TransMedics Acquires Organ Preservation Assets — Feb 21, 2025 Risk: medium
TransMedics Group, Inc. announced on February 20, 2025, the completion of its acquisition of certain assets related to Organ Preservation Solutions from Organog
TransMedics Completes OrganOx Acquisition — Jan 14, 2025 Risk: medium
TransMedics Group, Inc. announced the completion of its acquisition of OrganOx Limited on January 8, 2025. The acquisition was previously disclosed on December
TransMedics Completes OrganOx Acquisition — Dec 9, 2024 Risk: medium
TransMedics Group, Inc. announced the completion of its acquisition of OrganOx Limited on December 5, 2024. The acquisition was previously disclosed on October
TransMedics Appoints New Chief Medical Officer — Dec 2, 2024 Risk: low
TransMedics Group, Inc. announced on November 26, 2024, the appointment of Dr. David E. Pearse as Chief Medical Officer. Dr. Pearse, previously a Professor of S
TransMedics Group Files 8-K on Financials — Oct 28, 2024 Risk: low
TransMedics Group, Inc. filed an 8-K on October 28, 2024, to report on its results of operations and financial condition. The filing includes financial statemen
TransMedics Completes OrganOx Acquisition — Sep 11, 2024 Risk: medium
TransMedics Group, Inc. announced the completion of its acquisition of OrganOx Limited on September 6, 2024. The acquisition was previously disclosed in a Form
TransMedics Group Files 8-K on Financials — Jul 31, 2024 Risk: low
TransMedics Group, Inc. filed an 8-K on July 31, 2024, reporting on its results of operations and financial condition. The filing includes financial statements
TransMedics Acquires Organ Preservation Assets — Jul 29, 2024 Risk: medium
TransMedics Group, Inc. announced the completion of its acquisition of certain assets related to the Organ Preservation business from Organogenesis Holdings Inc
TransMedics Completes OCS Asset Acquisition — Jul 2, 2024 Risk: low
TransMedics Group, Inc. announced the completion of its acquisition of certain assets related to the Organ Care System (OCS) business from TransMedics, Inc. on
TransMedics Group Files 8-K on Shareholder Vote — May 28, 2024 Risk: low
TransMedics Group, Inc. filed an 8-K on May 28, 2024, reporting on matters submitted to a vote of security holders on May 23, 2024. The filing details the compa
TransMedics Group Files 8-K on Financials — Apr 30, 2024 Risk: low
TransMedics Group, Inc. filed an 8-K on April 30, 2024, reporting on its results of operations and financial condition. The filing includes financial statements
TransMedics Acquires XVIVO Organ Care System Assets — Mar 12, 2024 Risk: medium
TransMedics Group, Inc. announced on March 8, 2024, the completion of its acquisition of certain assets related to the Organ Care System (OCS) business from XVI
TransMedics Group Files 8-K on Financial Condition — Feb 26, 2024 Risk: low
TransMedics Group, Inc. filed an 8-K on February 26, 2024, to report on its results of operations and financial condition. The filing indicates that the company
TransMedics (TMDX) Completes Asset Acquisition/Disposition — Feb 6, 2024
TransMedics Group, Inc. (TMDX) filed an 8-K on February 6, 2024, reporting the completion of an acquisition or disposition of assets, with the earliest event da
TransMedics (TMDX) Reports Asset Acquisition/Disposition Completion — Jan 29, 2024
TransMedics Group, Inc. (TMDX) filed an 8-K on January 29, 2024, to report the completion of an acquisition or disposition of assets, with the earliest event re
TransMedics Completes Asset Acquisition/Disposition on Dec 29 — Jan 2, 2024
TransMedics Group, Inc. (TMDX) filed an 8-K on January 2, 2024, confirming the completion of an acquisition or disposition of assets on December 29, 2023. This

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX